Menarini International Operations Luxembourg S.A.
- A10 - Antidiabéticos
- OLTAR tablet 1 mg
- OLTAR tablet 2 mg
- OLTAR tablet 3 mg
- PRIGLIDE tablet 4 mg
- PRIGLIDE tablet 6 mg
- C01 - Terapia cardíaca
- RANEXA prolonged-release tablet 375 mg
- RANEXA prolonged-release tablet 500 mg
- RANEXA prolonged-release tablet 750 mg
- C07 - Betabloqueantes
- HYPOLOC COMP tablet 5 mg+12.5 mg
- HYPOLOC tablet 5 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- BIFRIL COMP film-coated tablet 30 mg+12.5 mg
- G04 - Urológicos
- SPEDRA tablet 100 mg
- SPEDRA tablet 200 mg
- SPEDRA tablet 50 mg
- J01 - Antibacterianos para uso sistémico
- TENKASI powder for solution for infusion 400 mg
- VABOREM powder and solvent for solution for infusion 1 g+1 g
- M01 - Antiinflamatorios y antirreumáticos
- KETESSE film-coated tablet 25 mg
- KETESSE oral solution 25 mg
- KETESSE solution for injection 50 mg/2 ml
- N02 - Analgésicos
- MIGARD film-coated tablet 2.5 mg
- SKUDEXA film-coated tablet 75 mg+25 mg
- SKUDEXA granules for oral solution 75 mg+25 mg
- R06 - Antihistamínicos para uso sistémico
- REVITELLE oral solution 2.5 mg/ml
- REVITELLE orodispersible tablet 10 mg
- REVITELLE tablet 20 mg